Ion Beam Applications SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Ion Beam Applications SA receives FDA approval of its new Compact Gantry
Ion Beam Applications SA (IBA):Announces that it has received Marketing Authorization from the U.S. Food and Drug Administration (FDA) for its Compact Gantry Beam Line.Says the company anticipates that this regulatory approval will intensify the international interest in Proteus ONE, IBA's next generation proton therapy compact system.
Latest Key Developments in Advanced
- Cerner Corp gives Q4 2014 guidance in line with analysts' estimates
- Edwards Lifesciences Corp sees FY 2014 revenue guidance to exceed high end of prior range; raises FY 2014 EPS guidance; gives Q4 2014 guidance in line with analysts' estimates
- Spectranetics Corp raises FY 2014 guidance
- Hamilton Thorne announces private placement unit offering of up to C$750,000
- Share this
- Digg this